Affomix Corporation
300 George Street
Suite 305
New Haven, CT 06511
www.affomix.com

Affomix Corporation will produce comprehensive libraries to isolate antibodies against at least two epitopes of each of the vast majority of proteins in the human proteome (Affomix defines a complete set of these antibodies as an 'affomeTM’). With such antibodies in hand, the Company’s mission will be to generate high complexity antibody microarrays for simultaneous qualitative and quantitative analyses of literally thousands of different proteins. Such microarrays would be superior not only to existing antibody arrays but also, for many applications, to nucleic acid microarrays.